Industry Research by Koncept Analytics
Global Lupus Nephritis Market: Industry Analysis & Outlook ----------------------------------------(2021-2030) May 2017
Global Lupus Nephritis Market: Industry Analysis & Outlook (2021-2030)
1
Executive Summary Lupus nephritis is inflammation of the kidney that is caused by systemic lupus erythematous (SLE). Also called lupus, SLE is an autoimmune disease where the immune system turns against the body, affecting vital organs. While the primary cause of the disease is unknown, it is expected that factors such as viruses, infections, pollutants, and toxic chemicals, along with family history plays a role in causing the disease. The disease is more common in women compared to men. Kidney damage from lupus erythematosus can vary from mild to severe. In lupus nephritis, glomeruli or the filtering units are damaged. As a result, waste from the blood does not get filtered. Lupus nephritis happens when lupus involves the kidneys. When the kidneys are inflamed, they cannot function normally and can leak protein. If not controlled, lupus nephritis can lead to kidney failure. The treatment for Lupus Nephritis is based upon on its type, which is determined by the biopsy. Since, symptoms and severity vary from person to person, treatments are individually tailored to meet a person's particular circumstances. The global Lupus Nephritis market is set to experience favourable growth driven by factors such as increasing African-American population, rising health care expenditure and accelerating economic growth. The major trends observed in the market are new drugs under pipeline for Lupus Nephritis, increasing research grants with rising public awareness about the disease. However, the growth of this budding market will be hindered by stringent regulations, associated risk and high cost. The report “Global Lupus Nephritis Market: Industry Analysis & Outlook (2021-2030)� analyses the development of this market, with focus on the U.S, Europe and Japan markets. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The five major players: Aurinia Pharmaceuticals Inc., Roche Holding AG, Bristol-Myers Squibb, GlaxoSmithKline Plc. and AstraZeneca are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global Lupus Nephritis market along with the study of the regional markets.
Global Lupus Nephritis Market: Industry Analysis & Outlook (2021-2030)
2
Rising African-American population and increasing health care expenditure supported the growth of lupus nephritis market. Global Lupus Nephritis Market Forecast by Value (20212030)
Global Lupus Nephritis Patient Population Forecast (20212030)
•
The global lupus nephritis market is estimated to reach US$ ..million by the year 2021, and would reach US$ ..million by year 2030, recording growth at a CAGR of ..% for the period spanning 2021-2030.
•
The global lupus nephritis patient population is anticipated to reach ..thousand by the year 2030, increasing from ..thousand in the year 2021, recording growth at a CAGR of ..% for the period spanning 2021-2030.
•
It is expected that by the year 2022, the U.S. would hold the largest market share of ..% followed by Japan and Europe with ..% shares respectively.
Global Lupus (2021/2030)
Nephritis
Market
by
Region
2030
2022
Global Lupus Nephritis Market: Industry Analysis & Outlook (2021-2030)
3
Accelerating economic growth and development of new biological drugs will drive the market for lupus nephritis globally.. The U.S. Lupus Nephritis Market Forecast by Value (20212030)
T The U.S. Lupus Nephritis Patient Population Forecast (20212030)
•
The U.S. lupus nephritis market is expected to reach US$ ..million by the year 2021, and would reach US$ ..million by year 2030, recording growth at a CAGR of ..% for the period spanning 2021-2030.
•
The U.S. lupus nephritis patient population is anticipated to reach ..thousand by the year 2030, increasing from ..thousand in the year 2021. The patient population is expected to grow at a CAGR of ..% for the period spanning 2021-2030.
•
In Japan, lupus nephritis market is expected to reach US$ ..million by the year 2022, and is further anticipated to reach US$ ..million by year 2030, recording growth at a CAGR of ..% for the period spanning 2022-2030. Japan Lupus Nephritis Market Forecast by Value (20222030)
Global Lupus Nephritis Market: Industry Analysis & Outlook (2021-2030)
4
Contact Us:
Disclaimer
This is a licensed product of Koncept Analytics. You cannot reproduce, publish, distribute, publicly display, sell or create other works from this report or use them in any way for commercial purpose without our prior permission. Further, you cannot copy this material, by any means (including electronic copies), for distribution to others unless you have purchased the corporate license of this report. We believe the sources are reliable, but Koncept Analytics does not warranty the accuracy or completeness of the data. The data presented in the report is updated at the publication date but is subject to change at subsequent releases. All possible efforts have been made to ensure accuracy of data. However, investors should not completely rely on the information given in this report and must make decisions based on their own investment strategy, risk management and capital adequacy.
Koncept Analytics CS-36, First Floor, Ansal Plaza Vaishali, Ghaziabad, U.P. – 201010 T: +91-120-4130959 M: +91-9811715635 vikas@konceptanalytics.com www.konceptanalytics.com
Global Lupus Nephritis Market: Industry Analysis & Outlook (2021-2030)
5